Normal Tension Glaucoma Clinical Trial
Official title:
Correlation Between Water Drinking Test Study and Disc Hemorrhages in Normal Tension Glaucoma
Disc hemorrhages are a known risk factor for progression of glaucoma. A positive water drinking test is also associated with progression of primary open glaucoma. The purpose of this study is to determine if patients with normal tension glaucoma and disc hemorrhages have a positive water drinking test. Patients with normal tension glaucoma and a disc hemorrhage will be recruited to undergo a water drinking test prior to any change in their treatment.
Patient with normal tension glaucoma under the care of a fellowship trained glaucoma specialist and noted to have a disc hemorrhage in one or both eyes when examined in the office will be recruited to undergo a water drinking test (WDT). After an informed consent is obtained, arrangements will be made to undergo the WDT either at the ophthalmologist's office or the local hospital clinic(Misericordia). The test will be administered in the following way: Upon arrival the patients baseline intraocular pressure (IOP) will be measured, then shortly afterwards the patient will drink 800 ml of water in a period of 5 minutes. Immediately after the water ingestion has finished a second IOP will be measured, followed by IOP measurements every 15 minutes for 60 minutes with a Goldman applanation tonometer by the same examiner. All of these measurements will be collected in a data sheet for the WTD. A total of 60 minutes would be the duration of the activity. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01995136 -
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Completed |
NCT00706056 -
A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure
|
N/A | |
Completed |
NCT01769521 -
Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG
|
N/A | |
Recruiting |
NCT01446497 -
Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma
|
Phase 4 | |
Terminated |
NCT01864317 -
Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging
|
Phase 2 | |
Not yet recruiting |
NCT00739154 -
Protective Effect of Phenytoin on Glaucoma
|
N/A | |
Recruiting |
NCT03761992 -
Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG
|
N/A | |
Recruiting |
NCT05371977 -
Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma
|
N/A | |
Completed |
NCT03106532 -
Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma
|
Phase 2 | |
Completed |
NCT01175902 -
Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma
|
N/A | |
Completed |
NCT01488032 -
Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma
|
N/A | |
Completed |
NCT00570362 -
Systemic Glutathione Level in Normal Tension Glaucoma
|
N/A | |
Recruiting |
NCT06449352 -
Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
|
Phase 4 | |
Not yet recruiting |
NCT06023927 -
Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
|
||
Completed |
NCT04475900 -
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
|
||
Completed |
NCT02863705 -
Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)
|
Phase 4 | |
Completed |
NCT00175786 -
Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma
|
N/A | |
Completed |
NCT03323164 -
Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study
|
Phase 4 | |
Completed |
NCT04014933 -
Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
|
||
Recruiting |
NCT01794442 -
Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins
|
N/A |